News
- Phase 2 Trial Tests New Drug Combinations That Could Reshape Tuberculosis Treatment
- Oral GLP-1 Pill Showing 11.8% Weight Loss Enters Large Phase III Trials
- Can Adding Dextromethorphan to Bupropion Help More Smokers Quit? Phase 3 Trial Begins
- Knee Injections for Osteoarthritis: Can a New Experimental Drug Outperform Hyaluronic Acid?
- Fueling the Aging Brain: Can Boosting NAD+ Slow Early Alzheimer’s Disease?
- Phase 3 trial will test whether treating pregnancy hypertension earlier can protect mothers and babies
- Three Biological Fluids, One Goal: How a New Approach to DNA Analysis Could Change Early Cancer Detection
- Once-daily oral GLP-1 drug ASC30 enters two large Phase 3 obesity trials
- An Unexpected Ally for Joints: Scientists Find a New Way to Ease Osteoarthritis Symptoms Using Prebiotics
- The First 1,000 Days: How a Historical Sugar Shortage Revealed an Unexpected Link to Alzheimer's Risk
- Breast Cancer Treatment Is Over, But Sleep Hasn't Returned: Smartphone Apps to Be Tested on 747 Women
- Hearing a Gasp Isn't Enough: Why a New Trial Adds Smartphone Video to Emergency Calls
- What an Exhale Can Tell: New Test to Be Trialed on 1,000 Patients with Suspected Stomach or Bowel Cancer
- Before the First Memory Problems: Roche to Test Drug in People with Alzheimer's Biomarkers
- A Diaper Photo Could Help Spot Liver Disease in Babies: UK Tests AI
- Tumor Remains After Treatment: New Combination to be Tested in 1,000 Patients with Aggressive Breast Cancer
- HIV Treatment Without Daily Pills: Gilead to Test New Long-Acting Regimen in Two Phase 3 Trials
- Tears Instead of Blood Tests: Scientists Create a Low-Cost Sensor for Monitoring Parkinson's Disease
- Smartphone vs. Silent Arrhythmia: Austria to Test Mass Screening for Stroke Prevention
- One Shot for Osteoarthritis? Scientists Report Joint Repair in Animals Within Weeks
- Pfizer to Test New Pneumococcal Vaccine for Children Needing Catch-up Immunization
- Tuberculosis Treatment Is a Long Marathon. A New Trial Will Test if It Can Be Shortened to 17 Weeks
- After a Type 1 Diabetes Diagnosis, the Race Against Time Begins. A New Trial Aims to Save Natural Insulin Production
- How Low Should "Bad" Cholesterol Go? Trial Tests New Target for Highest-Risk Patients
- DYNE-251 to Be Assessed in Phase 3 Trial in Patients with Duchenne Muscular Dystrophy
Clinical Research News
Upcoming Clinical Trials
-
Magnus MedicalCongressionally Directed Medical Research ProgramsRecruiting
-
Nicholas ButowskiSiren BiotechnologyNot yet recruitingGlioma | Brain Neoplasm | Recurrent High-Grade GliomasUnited States
-
State University of New York at BuffaloNot yet recruitingPatient EngagementUnited States
-
Poitiers University HospitalNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingSickle Cell Disease | Vaso-occlusive Crisis
-
University of California, IrvineRecruitingBrain Cancer | CNS Cancer | Nervous System Cancer | Brain Cancer MetastaticUnited States
-
Qualia Life SciencesRecruiting
-
Guangdong Raynovent Biotech Co., LtdNot yet recruiting
-
The Hong Kong Polytechnic UniversityWu Jieh Yee Charitable FoundationRecruitingAdults | Low Vision Digital Assistance | Visual ImpairmentsHong Kong
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingPancreatic Ductal Adenocarcinoma (PDAC)
-
Sun Yat-sen UniversityNot yet recruitingSmoking Cessation | AI Agent | Early-Stage Cancer
-
Affiliated Hospital of Nantong UniversityNot yet recruiting
